Alahuhta S, Räsänen J, Jouppila P, Kangas-Saarela T, Jouppila R, Westerling P, Hollmén A I
Department of Anaesthesiology, University of Oulu, Finland.
Anesthesiology. 1995 Jul;83(1):23-32. doi: 10.1097/00000542-199507000-00004.
Ropivacaine is a new long-acting amide local anesthetic that has been shown in animal studies to have less dysrhythmogenic and cardiotoxic potential than bupivacaine. The intravenous administration of ropivacaine has not been associated with any detrimental effects on uterine blood flow in pregnant ewes. The purpose of this randomized, double-blind study was to examine the effects of epidural ropivacaine for cesarean section on blood flow velocity waveforms in uteroplacental and fetal arteries with color Doppler ultrasound and to assess whether the block modified fetal myocardial function.
Healthy parturient women with singleton, uncomplicated pregnancies at term received 115-140 mg 0.5% ropivacaine (n = 11) or 0.5% bupivacaine (n = 10) in incremental epidural doses. The first ultrasound measurement was performed before injection of the study drug. Pulsatility indexes (PI) were derived for the blood flow velocity waveforms of the maternal placental and nonplacental uterine arteries; the placental arcuate artery; and the fetal umbilical, middle cerebral, and renal arteries. The fetal heart then was examined by echocardiography. The PI of the maternal uterine arteries and the fetal umbilical artery were measured 5 min after the injection of the local anesthetic. When sensory analgesia had reached the T6-T4 level, the ultrasound measurement was repeated with the same methods and targets as in the baseline measurement.
Both drugs provided adequate surgical anesthesia for cesarean section. In the bupivacaine group, the PI values for the maternal placental and nonplacental uterine arteries increased significantly 5 min after the main dose (P = 0.01, P = 0.002) and when sensory analgesia had reached the T6-T4 level (P = 0.004, P = 0.01) as compared with the baseline measurement. Simultaneously, the PI in the fetal middle cerebral artery decreased significantly (P = 0.02). The PI for the maternal uterine artery increased significantly (P = 0.01) after ropivacaine administration but only on the nonplacental side and not until sensory analgesia had reached the T6-T4 level. No effect on the Doppler indexes obtained from the umbilical artery was observed in either group. There were no significant differences relative to baseline values in any fetal myocardial measurement or in any ultrasound measurement between the groups. Neither drug had any detrimental effect on Apgar scores or umbilical cord acid-base status. None of the neonates' conditions was markedly depressed according to neurobehavioral testing.
Within this small study, epidural 0.5% ropivacaine for cesarean section did not compromise the utero-placental circulation in healthy parturient women with uncomplicated pregnancies. It provided surgical anesthesia that was equally effective as that provided by 0.5% bupivacaine.
罗哌卡因是一种新型长效酰胺类局部麻醉药,动物研究表明其致心律失常和心脏毒性潜力低于布比卡因。静脉注射罗哌卡因对妊娠母羊的子宫血流没有不良影响。这项随机、双盲研究的目的是,通过彩色多普勒超声检查剖宫产硬膜外使用罗哌卡因对子宫胎盘和胎儿动脉血流速度波形的影响,并评估这种阻滞是否改变胎儿心肌功能。
足月单胎、无并发症妊娠的健康产妇,接受递增硬膜外剂量的115 - 140 mg 0.5%罗哌卡因(n = 11)或0.5%布比卡因(n = 10)。首次超声测量在注射研究药物前进行。计算母体胎盘和非胎盘子宫动脉、胎盘弓状动脉以及胎儿脐动脉、大脑中动脉和肾动脉血流速度波形的搏动指数(PI)。然后通过超声心动图检查胎儿心脏。注射局部麻醉药5分钟后测量母体子宫动脉和胎儿脐动脉的PI。当感觉镇痛达到T6 - T4水平时,采用与基线测量相同的方法和指标重复超声测量。
两种药物均为剖宫产提供了充分的手术麻醉。在布比卡因组,主剂量注射后5分钟(P = 0.01,P = 0.002)以及感觉镇痛达到T6 - T4水平时(P = 0.004,P = 0.01),母体胎盘和非胎盘子宫动脉的PI值与基线测量相比显著增加。同时,胎儿大脑中动脉的PI显著降低(P = 0.02)。罗哌卡因给药后母体子宫动脉的PI显著增加(P = 0.01),但仅在非胎盘侧,且直到感觉镇痛达到T6 - T4水平才出现。两组均未观察到对脐动脉多普勒指标的影响。两组之间在任何胎儿心肌测量或任何超声测量中相对于基线值均无显著差异。两种药物对阿氏评分或脐带酸碱状态均无不良影响。根据神经行为测试,没有新生儿的状况明显受抑制。
在这项小型研究中,剖宫产硬膜外使用浓度为0.5%的罗哌卡因,对无并发症妊娠的健康产妇的子宫胎盘循环没有损害。它提供的手术麻醉效果与0.5%布比卡因相同。